Daniel K. Treiber

A quantitative analysis of kinase inhibitor selectivity

Mazen W. Karaman, Sanna Herrgård, Daniel K. Treiber et al. · Nature Biotechnology · 2008 · 2.4K citations

Drug Target, Signal Transduction, Medicine +6

Comprehensive analysis of kinase inhibitor selectivity

Mindy I. Davis, Jeremy P. Hunt, Sanna Herrgård et al. · Nature Biotechnology · 2011 · 2.3K citations · Full text

Drug Target, Signal Transduction, Medicine +5

A small molecule–kinase interaction map for clinical kinase inhibitors

Miles A. Fabian, William Biggs, Daniel K. Treiber et al. · Nature Biotechnology · 2005 · 1.9K citations · Full text

Molecular Docking, Drug Target, Clinical Kinase Inhibitors +4

Inhibition of drug-resistant mutants of ABL, KIT, and EGF receptor kinases

Todd A. Carter, Lisa Wodicka, Neil P. Shah et al. · Proceedings of the National Academy of Sciences · 2005 · 554 citations · Full text

Dual kinase-bromodomain inhibitors for rationally designed polypharmacology

Pietro Ciceri, Susanne Müller, Alison O’Mahony et al. · Nature Chemical Biology · 2014 · 347 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Medicine +6